V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004585 | 300003205 | 1.72 | 58.6 | Adjuvant (A) | 2017-02-15 | 2017-02-19 | GemCarbo Days 1+8 | 2 | N | 300024435 | FLUOROURACIL |
| 300004586 | 300003206 | 1.68 | 93.5 | Curative (C) | 2016-06-01 | 2016-06-15 | TCF | N | Y | 300024443 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004587 | 300003206 | 1.62 | 58.7 | Palliative (P) | 2014-11-22 | 2014-11-22 | Hydroxycarbamide | 01 | N | 300024443 | BEVACIZUMAB |
| 300004588 | 300003207 | 1.64 | 91 | Curative (C) | 2017-11-19 | 2017-11-20 | IPILIMUMAB + NIVOLUMAB | N | N | 300024471 | CISPLATIN + FLUOROURACIL + RT |
| 300004589 | 300003207 | 1.75 | 81.2 | null | null | 2015-08-08 | GemCarbo Days 1+8 | 2 | null | 300024471 | DA |
| 300004590 | 300003208 | null | 58.3 | Adjuvant (A) | 2017-05-24 | 2017-06-05 | CAPECITABINE + GEMCITABINE | N | N | 300024475 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004591 | 300003208 | 1.76 | 79.65 | Palliative (P) | 2017-09-16 | 2017-09-17 | FLUOROURACIL + OXALIPLATIN | 02 | N | 300024475 | ESPAC TRIAL |
| 300004592 | 300003209 | 1.56 | 54.1 | Palliative (P) | 2017-11-23 | 2017-12-02 | Cisplatin + Pemetrexed | N | N | 300024489 | CARBOPLATIN + ETOPOSIDE |
| 300004593 | 300003210 | null | 85.1 | Adjuvant (A) | 2013-03-01 | 2013-03-28 | DE-ESCALATE TRIAL | N | N | 300024491 | HYDROXYCARBAMIDE |
| 300004594 | 300003210 | 1.62 | null | Disease modification (D) | 2014-08-14 | 2014-08-25 | ESPAC-4 TRIAL | N | N | 300024491 | CAPECITABINE + GEMCITABINE |
| 300004595 | 300003210 | 1.77 | null | Palliative (P) | 2017-12-27 | 2018-01-17 | CARBOPLATIN + RT | N | N | 300024491 | CISPLATIN + DOCETAXEL |
| 300004596 | 300003210 | 1.51 | 63.4 | Adjuvant (A) | 2016-03-08 | 2016-03-18 | Gemcitabine + Capecitabine | N | N | 300024491 | PEMBROLIZUMAB |
| 300004597 | 300003210 | 1.74 | 49 | Adjuvant (A) | 2015-08-07 | 2015-08-07 | ESPAC-4 TRIAL | 02 | N | 300024491 | BEVACIZUMAB |
| 300004598 | 300003210 | 1.81 | 83 | Palliative (P) | 2016-04-22 | 2016-04-22 | GEMCITABINE + NAB PACLITAXEL | 2 | N | 300024491 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004599 | 300003210 | 1.6 | 80 | Palliative (P) | 2018-03-31 | 2018-04-05 | ABC-02 TRIAL | 02 | N | 300024491 | CARBOPLATIN + ETOPOSIDE |
| 300004600 | 300003211 | 1.6 | 68.2 | Curative (C) | 2016-07-14 | 2016-08-11 | CARBOPLATIN + RT | Y | Y | 300024526 | CAPECITABINE + GEMCITABINE |
| 300004601 | 300003212 | 1.82 | 75 | Palliative (P) | 2014-09-13 | 2014-10-04 | ECarboX | N | N | 300024529 | ESPAC TRIAL |
| 300004602 | 300003213 | null | 63.8 | Palliative (P) | 2015-03-04 | 2015-03-31 | VAI (Ifos 3g/m2) | Y | N | 300024533 | CARBOPLATIN + ETOPOSIDE |
| 300004603 | 300003214 | 1.71 | 46.6 | Curative (C) | 2015-11-06 | 2015-12-15 | EOX | 02 | N | 300024538 | GEMCARBO |
| 300004604 | 300003215 | 1.77 | 63 | Palliative (P) | 2017-10-01 | 2017-10-03 | Mitotane 2g | 02 | N | 300024548 | ECARBOX |
| 300004605 | 300003216 | 1.65 | 53.2 | Not known (9) | 2015-07-07 | 2015-07-21 | Gemcitabine + Capecitabine | 02 | N | 300024553 | CISPLATIN + ETOPOSIDE |
| 300004606 | 300003216 | 1.62 | 56.7 | Palliative (P) | 2014-10-14 | 2014-10-15 | Folfirinox | 02 | null | 300024553 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004607 | 300003216 | 1.76 | 82 | Disease modification (D) | 2017-03-13 | 2017-03-18 | Capecitabine + Oxaliplatin 21day | N | N | 300024553 | CARBOPLATIN |
| 300004608 | 300003217 | 1.57 | 89.5 | Curative (C) | 2016-03-21 | 2016-03-21 | EOX | 2 | N | 300024569 | CAPECITABINE + CISPLATIN |
| 300004609 | 300003218 | 1.7 | 60.7 | Palliative (P) | 2015-01-24 | 2015-02-18 | PEMBROLIZUMAB | N | N | 300024571 | DABRAFENIB |
| 300004610 | 300003218 | 1.53 | 95 | Curative (C) | 2016-10-06 | 2016-10-09 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | null | 300024571 | CAPECITABINE + GEMCITABINE |
| 300004611 | 300003218 | 1.76 | 67.1 | Neo-adjuvant (N) | 2017-01-10 | 2017-01-14 | ESPAC-4 TRIAL | N | N | 300024571 | ESPAC TRIAL |
| 300004612 | 300003219 | 1.83 | 95.1 | Adjuvant (A) | 2016-03-21 | 2016-03-21 | DE-ESCALATE TRIAL | 02 | N | 300024581 | CISPLATIN + VINORELBINE |
| 300004613 | 300003220 | 1.73 | null | Adjuvant (A) | 2016-10-17 | 2016-10-29 | VAI (Ifos 3g/m2) | N | N | 300024586 | CARBOPLATIN + RT |
| 300004614 | 300003221 | 1.49 | 70.2 | Curative (C) | 2014-06-08 | 2014-06-12 | EC | 2 | N | 300024595 | FLUOROURACIL |
| 300004615 | 300003221 | 1.88 | 84.5 | Not known (9) | 2016-12-17 | 2016-12-27 | Folfirinox | 02 | null | 300024595 | CARBO + FLUOROURACIL |
| 300004616 | 300003221 | 1.57 | 113 | Disease modification (D) | 2014-03-29 | 2014-04-20 | FEC 60 or 75 | N | N | 300024595 | CARBOPLATIN + RT |
| 300004617 | 300003222 | 1.77 | 88 | Adjuvant (A) | 2013-08-07 | 2013-08-14 | ESPAC-4 TRIAL | 02 | N | 300024619 | CAPECITABINE + OXALIPLATIN |
| 300004618 | 300003222 | 1.78 | 141 | Curative (C) | 2017-05-22 | 2017-05-23 | CARBOPLATIN + RT | N | N | 300024619 | ESPAC TRIAL |
| 300004619 | 300003222 | 1.64 | 62.1 | Palliative (P) | null | 2013-10-20 | GEMCARBO | 2 | null | 300024619 | CARBOPLATIN + ETOPOSIDE |
| 300004620 | 300003223 | 1.66 | 113.8 | Palliative (P) | 2017-08-10 | 2017-08-17 | CARBOPLATIN + RT | Y | N | 300024634 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004621 | 300003223 | 0 | 76.3 | Palliative (P) | 2013-12-23 | 2014-01-04 | GemCarbo Days 1+8 | 02 | null | 300024634 | MITOTANE |
| 300004622 | 300003223 | 1.7 | null | Disease modification (D) | 2017-07-16 | 2017-08-24 | Paclitaxel (2 or 3 weekly) | N | N | 300024634 | FLUOROURACIL + MITOMYCIN + RT |
| 300004623 | 300007988 | null | 79.1 | Adjuvant (A) | 2015-06-29 | 2015-06-30 | Carboplatin AUC 6 - 10 | 02 | N | 300024651 | ESPAC TRIAL |
| 300004624 | 300007988 | 1.64 | 57 | Palliative (P) | 2016-08-22 | 2016-09-07 | null | N | N | 300024651 | FLUOROURACIL + MITOMYCIN + RT |
| 300004625 | 300008313 | 1.59 | 90 | Curative (C) | 2017-02-19 | 2017-04-05 | Folfirinox | Y | Y | 300024654 | DABRAFENIB |
| 300004626 | 300008313 | null | 73.7 | null | 2015-09-15 | 2015-09-28 | CISPLATIN + FLUOROURACIL + RT | N | N | 300024654 | DE-ESCALATE TRIAL |
| 300004627 | 300003224 | null | 74.2 | Curative (C) | 2013-10-16 | 2013-11-13 | FLUOROURACIL + MITOMYCIN | N | Y | 300024682 | CAPECITABINE + GEMCITABINE |
| 300004628 | 300006159 | 1.66 | 79.9 | Curative (C) | 2015-09-04 | 2015-09-11 | Cisplatin + Paclitaxel | N | Y | 300024691 | NOT MATCHED |
| 300004632 | 300003228 | 1.61 | 58 | Adjuvant (A) | 2016-02-12 | 2016-02-25 | CARBOPLATIN + RT | 02 | N | 300024703 | CARBOPLATIN |
| 300004633 | 300003228 | 1.86 | 75.6 | Curative (C) | 2013-07-13 | 2013-07-17 | DE-ESCALATE TRIAL | 02 | N | 300024703 | CARBOPLATIN + RT |
| 300004634 | 300003228 | null | 68 | Palliative (P) | 2016-11-27 | 2016-12-03 | FLUOROURACIL | null | N | 300024703 | PACLITAXEL |
| 300004635 | 300003229 | 1.51 | null | Adjuvant (A) | 2017-01-30 | 2017-01-31 | FLUOROURACIL + MITOMYCIN + RT | N | N | 300024712 | ESPAC TRIAL |
| 300004636 | 300003230 | 1.59 | 54 | Adjuvant (A) | 2018-02-03 | 2018-02-11 | CARBOPLATIN + FLUOROURACIL | 2 | N | 300024713 | ESPAC TRIAL |
| 300004637 | 300003230 | null | 63.7 | Curative (C) | 2016-11-08 | 2016-11-08 | FEC + DOCETAXEL | 02 | null | 300024713 | DE-ESCALATE TRIAL |